- Home
- PAYS vs NKTR Comparison
PAYS vs NKTR Comparison
Compare PAYS & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYS
- NKTR
- Stock Information
- Founded
- PAYS 2001
- NKTR 1990
- Country
- PAYS United States
- NKTR United States
- Employees
- PAYS N/A
- NKTR N/A
- Industry
- PAYS Business Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- PAYS Consumer Discretionary
- NKTR Health Care
- Exchange
- PAYS Nasdaq
- NKTR Nasdaq
- Market Cap
- PAYS 125.2M
- NKTR 125.5M
- IPO Year
- PAYS 1998
- NKTR 1994
- Fundamental
- Price
- PAYS $5.45
- NKTR $8.51
- Analyst Decision
- PAYS Strong Buy
- NKTR Strong Buy
- Analyst Count
- PAYS 4
- NKTR 6
- Target Price
- PAYS $6.56
- NKTR $73.75
- AVG Volume (30 Days)
- PAYS 503.5K
- NKTR 352.6K
- Earning Date
- PAYS 07-30-2025
- NKTR 08-07-2025
- Dividend Yield
- PAYS N/A
- NKTR N/A
- EPS Growth
- PAYS N/A
- NKTR N/A
- EPS
- PAYS 0.11
- NKTR N/A
- Revenue
- PAYS $63,792,627.00
- NKTR $87,248,000.00
- Revenue This Year
- PAYS $30.03
- NKTR N/A
- Revenue Next Year
- PAYS $20.14
- NKTR N/A
- P/E Ratio
- PAYS $49.74
- NKTR N/A
- Revenue Growth
- PAYS 26.77
- NKTR N/A
- 52 Week Low
- PAYS $1.80
- NKTR $6.48
- 52 Week High
- PAYS $5.59
- NKTR $22.79
- Technical
- Relative Strength Index (RSI)
- PAYS 77.72
- NKTR 42.19
- Support Level
- PAYS $4.72
- NKTR $7.99
- Resistance Level
- PAYS $5.10
- NKTR $9.71
- Average True Range (ATR)
- PAYS 0.27
- NKTR 1.37
- MACD
- PAYS 0.00
- NKTR -0.20
- Stochastic Oscillator
- PAYS 91.18
- NKTR 11.66
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.